Âé¶¹´«Ã½ merchant banking portfolio company: CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
Âé¶¹´«Ã½ Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business
Âé¶¹´«Ã½ Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group
Âé¶¹´«Ã½ Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share